High local recurrence risk after breast-conserving therapy in node- negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European organization for research and treatment of cancer breast cancer cooperative group study

Journal of Clinical Oncology

Volumn 18, Issue 5, 2000, Pages 1075-1083

  Elkhuizen, Paula H M ^a   Van Slooten, Henk Jan ^a   Clahsen, Pieter C ^a   Hermans, Jo ^a   Van De Velde, Cornelis J H ^a   Van Den Broek, Lambert C J M ^a   Van De Vijver, Marc J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0033993447     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.5.1075     Document Type: Article

References (44)

1. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
2. Borger J, Kemperman H, Hart A, et al: Risk factors in breast-conservation therapy. J Clin Oncol 12:653-660, 1994
3. Gage I, Recht A, Gelman R, et al: Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys 33:245-251, 1995
4. Fourquet A, Campana F, Zafrani B, et al: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 17:719-725, 1989
5. Elkhuizen PHM, van de Vijver MJ, Hermans J, et al: Local recurrence after breast conserving treatment: High incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40:859-867, 1998
6. Levine MN, Bramwell V, Abu-Zahra H, et al: The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation. Br J Cancer 65:130-132, 1992
7. Haffty BG, Wilmarth L, Wilson L, et al: Adjuvant systemic chemotherapy and hormonal therapy: Effect on local recurrence in the conservatively treated breast cancer patients. Cancer 73:2543-2548, 1994
8. Rose MA, Henderson C, Gelman R, et al: Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 17:711-717, 1989
9. Haffty BG, Fischer D, Rose M, et al: Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data. J Clin Oncol 9:997-1003, 1991
10. Voogd AC, Nielsen JL, Blichert-Toft M, et al: Are risk factors for local and distant recurrence after breast-conserving therapy for stage I and II breast cancer similar to those after mastectomy? Eur J Cancer 34: S46, 1998 (abstr 192)
11. Whelan T, Clark R, Roberts R, et al: Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Result from a randomized trial. Int J Radiat Oncol Biol Phys 30:11-16, 1994
12. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996
13. Fisher B, Anderson S, Fisher ER, et al: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331, 1991
14. Fortin A, Larochelle M, Laverdiere J, et al: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17:101-109, 1999
15. Clahsen PC, van de Velde CJH, Goldhirsch A, et al: Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer. J Clin Oncol 15:2526-2535, 1997
16. Clahsen PC, van de Velde CJH, Duval CD, et al: P53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. J Clin Oncol 16:470-479, 1998
17. Clahsen PC, van de Velde CJH, Julien J-P, et al: Thromboembolic complications after perioperative chemotherapy in women with early breast cancer. J Clin Oncol 12:1266-1271, 1994
18. Elston CW, Ellis IO: Pathologic prognostic factors in breast cancer: I. The value of histological grade in breast cancer - Experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
19. Holland R, Peterse JL, Millis RR, et al: Ductal carcinoma in situ: A proposal for a new classification. Semin Diagn Pathol 11:167-180, 1994
20. van Slooten H-J, Clahsen PC, van Dierendonck JH, et al: Expression of bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of peri-operative chemotherapy. Br J Cancer 74:78-85, 1996
21. van de Vijver MJ, Peterse JL, Mooi WJ, et al: Neu-protein overexpression in breast cancer. N Engl J Med 319:1239-1245, 1988
22. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastases-correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
23. Matthews DE, Farewell VT: Using and Understanding Medical Statistics (ed 3, rev). Basel, Switzerland, Karger, 1996
24. Curran D, van Dongen JA, Aaronson NK, et al: Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: Results of EORTC trial 10801 - The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). Eur J Cancer 34:307-314, 1998
25. Elkhuizen PHM, Voogd AC, van den Broek LCJM, et al: Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 45:73-83, 1999
26. Lowe SW, Bodis S, McClatchey A, et al: p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810, 1994
27. Degeorges A, de Ranquancourt A, Extra JM, et al: Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer? Breast Cancer Res Treat 47:47-55, 1998
28. Wilson LD, Beinfield M, McKhann CF, et al: Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancer. Cancer 72:137-142, 1993
29. Kurtz JM, Jacquemier J, Amalric F, et al: Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 212:38-44, 1990
30. Leopold KA, Recht A, Schnitt SJ, et al: Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 16:11-16, 1989
31. Fowble BL, Yeh IT, Schultz DJ, et al: The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys 27:567-573, 1993
32. Jacquemier J, Kurtz JM, Amalric R, et al: An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer 61:873-876, 1990
33. Bartelink H, Borger J, van Dongen JA, et al: The impact of tumor size and histology on local control after breast conserving therapy. Radiother Oncol 11:297-303, 1988
34. Lindley R, Bulman A, Parsons P, et al: Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy. Surgery 105:13-20, 1987
35. Vicini FA, Recht A, Abner A, et al: Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr 11:33-39, 1992
36. Veronesi U, Volterrani F, Luini A, et al: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26:671-673, 1990
37. Veronesi U, Marubini E, DelVecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
38. Schnitt SJ, Abner A, Gelman R, et al: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74:1746-1751, 1994
39. Fisher ER, Anderson S, Redmond C, et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 8:161-166, 1992
40. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer 75:1310-1319, 1995
41. Gunduz N, Fisher B, Saffer EA: Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39:3861-3865, 1979
42. Hartsell WF, Recine DC, Griem KL, et al: Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 76:2497-2503, 1995
43. Recht A, Come SE, Henderson IC, et al: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334:1356-1361, 1996
44. Recht A, Come SE, Gelman RS, et al: Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early stage, node-positive breast cancer: Sequencing, timing and outcome. J Clin Oncol 9:1662-1667, 1991